Literature DB >> 966583

[Echography of the vitreous body in case of aphakia and malignant aphakic glaucoma (author's transl)].

W Buschmann, D Linnert.   

Abstract

The senile destructions of the vitreous body which can be seen with the slit-lamp (formation of visible fibres, vacuoles and posterior vitreous detachment) cause, if sufficiently advanced, small echoblips visible at echographic examination. We reexamined aphakic patients who had no complications during cataract cryo-extraction. In aphakic eyes without postoperative vitreous prolapse into the anterior chamber the echograms usually consisted of uninterrupted series of small amplitude echoes in the vitreous area. In aphakic eyes with postoperative vitreous prolapse into the anterior chamber echo-free parts were found in the vitreous area and also parts showing closer placing of vitreous echoes. The echo-free parts may represent fluid-filled vacuoles. In malignant aphakic glaucomas, which could not be controlled otherwise, we succeeded inaspirating aqueous humour from these echo-free parts by punction. Echography facilitated, in this way, the punction of the trapped aqueous. Echography of the senile vitreous destructions approaches the limits of present ultrasonographic facilities; artefacts may occur, and technical improvements are desirable and possible.

Entities:  

Mesh:

Year:  1976        PMID: 966583

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Acute aphakic pupil block glaucoma: an alternative surgical approach.

Authors:  R A Hitchings
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

2.  A refractory malignant glaucoma posttrabeculectomy in vitrectomized eye: A case report and review of the literature.

Authors:  Hung-Chi Lai; Kwou-Yeung Wu; Han-Yi Tseng
Journal:  Taiwan J Ophthalmol       Date:  2020-02-14

Review 3.  Clinical Management of Malignant Glaucoma.

Authors:  Julie Foreman-Larkin; Peter A Netland; Sarwat Salim
Journal:  J Ophthalmol       Date:  2015-12-24       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.